Officers seized four pill presses and over a kilogram of illicit drugs while dismantling a pill press operation in Jacksonville, Florida
There is no demonstrable ROI within the pharmacy benefit for employer health plans covering GLP-1s for weight loss at current prices
Gag Clause Prohibition Compliance Attestation as Mandated by the Consolidated Appropriations Act As we approach the December deadline for the Consolidated Appropriations Acts Gag Clause Prohibition Compliance Attestation (GCPCA) , carriers are beginning to provide related guidance
or subscribe to save 40% Sale!Sale!as low as $35.91 $66.50 Lean Full Coverage Combo $66.50 Original price was: $66.50.$59.85Current price is: $59.85
Omzo's brand materials describe tirzepatide as offering "dual-hormone support that targets appetite, blood sugar, and metabolism for deeper, sustained progress." Clinical trials of tirzepatide (the active ingredient in Zepbound and Mounjaro) have shown substantial weight loss outcomes in studied populations, and some trials have shown greater average weight reduction with tirzepatide compared to semaglutide in head-to-head comparisons - though individual responses vary and neither medication is appropriate for all patients
No recent cardiovascular issues